These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2581591)

  • 1. Studies on hydroxyethyl starch. Part II: Changes of the molecular weight distribution for hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3 and 200/0.1 after infusion in serum and urine of volunteers.
    Ferber HP; Nitsch E; Förster H
    Arzneimittelforschung; 1985; 35(3):615-22. PubMed ID: 2581591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The in vivo molecular weight and renal threshold of hydroxyethyl starch in the example of molar substituted HES70/0/5].
    Förster H; Lehmann G; Asskali F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jan; 36(1):31-7. PubMed ID: 11227306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mathematical decription of the human intravascular elimination of HAS after repeated infusions].
    Mishler JM; Beez M
    Infusionsther Klin Ernahr; 1979 Apr; 6(2):119-22. PubMed ID: 85606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
    Mishler JM
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
    Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on hydroxyethyl starch. Part I: Molecular characterization by size exclusion chromatography coupled with low-angle laser light scattering.
    Lederer K; Huber C; Dunky M; Fink JK; Ferber HP; Nitsch E
    Arzneimittelforschung; 1985; 35(3):610-4. PubMed ID: 2581590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of an infusion with middle molecular weight hydroxyethyl starch (HAES-steril 10%) on the flow properties of blood in healthy probands].
    Landgraf H; Ehrly AM; Saeger-Lorenz K; Vogel C
    Infusionsther Klin Ernahr; 1981 Aug; 8(4):200-4. PubMed ID: 6168586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
    Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs.
    Yacobi A; Gibson TP; McEntegart CM; Hulse JD
    Res Commun Chem Pathol Pharmacol; 1982 May; 36(2):199-204. PubMed ID: 6179136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
    Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
    Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch-induced macroamylasemia.
    Köhler H; Kirch W; Horstmann HJ
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):428-31. PubMed ID: 72048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes].
    Jesch F; Hübner G; Zumtobel V; Zimmermann M; Messmer K
    Infusionsther Klin Ernahr; 1979 Apr; 6(2):112-7. PubMed ID: 85605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary excretion of hydroxyethyl starch in man.
    Kalhorn TF; Yacobi A; Sum CY
    Biomed Mass Spectrom; 1984 Apr; 11(4):164-6. PubMed ID: 6203566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improvement of the flow properties of the blood of patients by low-molecular hydroxyethyl starch (Expafusin)].
    Landgraf H; Ruppel C; Saeger-Lorenz K; Vogel C; Ehrly AM
    Infusionsther Klin Ernahr; 1982 Aug; 9(4):202-6. PubMed ID: 6182099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the C2/C6 ratio of high-molecular-weight hydroxyethyl starch on pharmacokinetics and blood coagulation in pigs.
    Schramm S; Thyes C; Frascarolo P; Buclin T; Burki M; Fisch A; Burmeister MA; Asmis L; Spahn DR
    Anesthesiology; 2007 Sep; 107(3):442-51. PubMed ID: 17721247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethyl starch: the effect of molecular weight and degree of substitution on intravascular retention in vivo.
    Hitosugi T; Saito T; Suzuki S; Kubota I; Shoda E; Shimizu T; Oi Y
    Anesth Analg; 2007 Sep; 105(3):724-8. PubMed ID: 17717230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.